May 30, 2026 to June 3, 2026
Henry Cheng International Conference Centre
Asia/Hong_Kong timezone

Contribution List

88 out of 88 displayed
  1. Jiekai Hua
    Others

    A Multi-Stage Strategy to Decipher the Pharmacodynamic Material Basis of Qiliqiangxin Capsules for Heart Failure Therapy
    Jiekai Hua a,b 1, Jianwei Zhang b 1, Sijia Wu b,c 1, Qingyin Feng a,b, Guosheng Fu b, Chunhui Li d, Ying Chen b, Sijie Liu b, Jie Shen b , Shuling Wang a, Wei Liu a,b *
    Affiliations:
    a School of Pharmacy, Hangzhou Normal University; Key Laboratory of Elemene Class...

    Go to contribution page
  2. Ling Yang (Zunyi Medical University)
    New Tools for Studying Drug Metabolism

    Abstract:
    Background: Accurate prediction of metabolic drug-drug interactions (DDIs) is crucial for clinical medication. However, current predominant prediction models are limited. This study was designed to address these limitations by developing a new predictive model that is both accurate and readily applicable.
    Methods: A simplified predictive model for metabolic DDIs was developed...

    Go to contribution page
  3. Minsoo Lee (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea)
    DMPK (Drug Metabolism and Pharmacokinetics) of New Molecules

    Background: Propranolol is a widely used beta-blocker that exhibits rapid oral absorption, high hepatic extraction, and extensive tissue distribution. Although its absorption and disposition kinetics have been well-documented, interspecies similarities and differences have not been systematically assessed within a unified translational framework. This study aimed to characterize the...

    Go to contribution page
  4. Mr Weilong Gu (University of Toronto)
    Cytochrome P450 Enzymes (CYPs)

    Background: In humans, CYP2A6, the principal enzyme for coumarin and nicotine metabolism, shows wide interindividual genetic variation and environmental regulation, complicating the determination of age- and sex-related differences. African green monkeys, with comparable CYP2A6 activity to humans, were used to investigate age- and sex-effects on CYP2A6 activity.
    Methods: Liver and...

    Go to contribution page
  5. Prof. Ling Yang (Zunyi Medical University)
    New Tools for Studying Drug Metabolism

    Abstract
    Background: As a typical prodrug, the clinical application of flurbiprofen axetil is limited by premature hydrolysis mediated by intestinal carboxylesterase 2 (CES2). This premature hydrolysis leads to local accumulation of the active metabolite flurbiprofen in the gastrointestinal tract, causing toxicity, while insufficient systemic exposure results in limited therapeutic efficacy....

    Go to contribution page
  6. Yuan Wei (Jiangsu University)
    Drug-Drug and Herb-Drug Interactions

    Triptolide (TP), the primary bioactive constituent of the traditional Chinese medicine Tripterygium wilfordii, is renowned for its potent pharmacological activities. However, its clinical application is severely restricted by significant hepatotoxicity. Current therapeutic strategies for TP-induced liver injury are limited. In clinical practice, TP is often co-administered with...

    Go to contribution page
  7. Jed Lampe (University of Colorado)
    New Tools for Studying Drug Metabolism

    Background: In vitro models of human liver development are crucial for studying the impact of xenobiotic exposure on the developing fetus and neonate. However, the limited availability of fetal and neonatal primary human hepatocytes (PHHs) makes it difficult to conduct these studies, leaving these populations vulnerable to empirical drug dosing and possible related toxicities.

    Methods:...

    Go to contribution page
  8. Dr Katyayani Sharma (University of Bern), Prof. Amit V Pandey (University of Bern, Switzerland)
    Metabolism of Natural Products and Endogenous Substances

    The pharmacological modulation of androgens is a cornerstone of managing conditions ranging from hypogonadism to polycystic ovary syndrome (PCOS). However, a major validation gap currently separates the aggressive marketing of commercial supplements from rigorous evidence-based endocrinology. Our analysis critically synthesizes mechanistic and clinical data for multiple natural products to...

    Go to contribution page
  9. Xiaowen Jiang (Southern Medical University)
    Others

    Background: Cholestasis is a clinical syndrome of toxic bile acid accumulation due to impaired bile flow, categorized as intrahepatic or extrahepatic, with limited treatment options. Emerging evidence implicates gut microbiota dysregulation in cholestatic liver disease, although its precise mechanistic role remains unclear.
    Methods: Intrahepatic and extrahepatic cholestasis models...

    Go to contribution page
  10. Dr Ying Tian (Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan)
    Nuclear Receptors & Noncoding RNAs in Drug Metabolism

    Background: Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a chronic liver disorder characterized by disrupted lipid metabolism. The aryl hydrocarbon receptor (AHR), a ligand-dependent transcription factor, is involved in regulating various physiological processes, such as lipid metabolism and immune responses. Recent studies have highlighted the multifaceted regulatory role...

    Go to contribution page
  11. Giovanna Di Nardo (University of Torino)
    Cytochrome P450 Enzymes (CYPs)

    Background: The estrogen axis is regulated through coordinated control of steroid hormone biosynthesis and receptor-mediated transcription. Disruption at either level can alter reproductive, developmental, metabolic, and oncogenic processes.
    We developed and applied an integrated approach to identify compounds that target both levels of estrogen regulation: human aromatase (CYP19A1) and...

    Go to contribution page
  12. Jing Jin (University of Connecticut)
    New Tools for Studying Drug Metabolism

    This oral presentation highlights the use of human microphysiological systems (MPS) to evaluate the efficacy, absorption, distribution, metabolism, and excretion (ADME), as well as the toxicity of antisense oligonucleotide (ASO) and small interfering RNA (siRNA) therapeutics. The talk will discuss how advanced MPS models better recapitulate human physiology compared with conventional in vitro...

    Go to contribution page
  13. Hae Chan Jeong (Chonnam National University)
    New Tools for Studying Drug Metabolism

    Submission Type: Poster Presentation
    Submitted by: Hae Chan Jeong (Chonnam National University, KR)
    Track: New Tools for Studying Drug Metabolism
    Biocatalytic synthesis of a novel atorvastatin derivative as an anti-hyperlipidemic drug candidate using sequential reaction of P450 and tyrosinase
    Hae Chan Jeong1, Yu-Jin Lee1, Gun Su Cha2, Fikri A. R. Hardiyanti Oktavia1, Chan Mi Park2, Chul-Ho...

    Go to contribution page
  14. Weikang Ban (School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong)
    Drug-Drug and Herb-Drug Interactions

    Background: Among all the treatments for ischemic stroke, antiplatelet therapy with aspirin (ASA) and clopidogrel (CLP), known as dual antiplatelet therapy (DAPT), and ginkgo diterpene lactone meglumine injection (GDLI) are considered as the first line therapeutic approach for western medicine and Chinese medicine, respectively. Since carboxylesterase 1 (CES1) is the predominant hydrolase...

    Go to contribution page
  15. Yixuan Wang (Fourth Military Medical University)
    Cytochrome P450 Enzymes (CYPs)

    Background: Sterol 12α-hydroxylase (CYP8B1) is a promising target for treating metabolic diseases. However, developing selective inhibitors is hindered by incomplete methodologies and the absence of structural guidance. To overcome this, this study adopts an alternative strategy of screening plant-derived triterpenoids and animal bile acids as candidate inhibitors, leveraging their...

    Go to contribution page
  16. Sunyu Song (Konkuk University, Department of Biological Sciences, Seoul 05029, Korea)
    Cytochrome P450 Enzymes (CYPs)

    Background: Cytochrome P450 11A1 (CYP11A1) is a mitochondrial cytochrome P450 enzyme that catalyzes the conversion of cholesterol to pregnenolone, the first step in steroid hormone biosynthesis, thereby playing a critical role in regulating diverse physiological processes. CYP11A1 requires two redox partners, adrenodoxin reductase (AdR) and adrenodoxin (Adx), to receive electrons from NADPH....

    Go to contribution page
  17. Rajamanikkam Kamaraj (Charles University)
    Nuclear Receptors & Noncoding RNAs in Drug Metabolism

    The pregnane X receptor (PXR) is an important regulator of hepatic metabolism, yet mechanistic insights into the effects of pharmacological inhibition using PXR inverse agonists or antagonists on critical genes involved in both xenobiotic and endobiotic metabolism remain limited.
    Here, we discovered a novel PXR inverse agonist/antagonist, MI891, which binds to the ligand-binding domain of...

    Go to contribution page
  18. Hyeonseo Park (Konkuk University)
    Cytochrome P450 Enzymes (CYPs)

    Background: CYP11B1 and CYP11B2 are key enzymes in corticosteroid biosynthesis. The metabolites produced by these enzymes regulate essential physiological processes, including immune function and stress responses. Because the two enzymes share approximately 93% amino acid sequence identity, achieving selective inhibition of one over the other is challenging. Therefore, the objective of this...

    Go to contribution page
  19. Junling Yang (Shanghai Institute of Materia Medica, Chinese Academy of Sciences,)
    Metabolism of Natural Products and Endogenous Substances

    Background: Compound Danshen droplet pill, containing Salvia miltiorrhiza root (Danshen), Panax notoginseng root (Sanqi), and Borneolum syntheticum (Bingpian), is widely used for chronic stable angina. Two key pharmacokinetic questions are: “Which constituents are of significantly oral bioavailability and so merit pharmacodynamic study?” and “Whether the pill’s components are of...

    Go to contribution page
  20. Mária Bajnoková (Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles 14 University, Akademika Heyrovskeho 1203, 500 05, Hradec Kralove, Czech Republic)
    Drug Metabolism under Different Physiological Conditions

    Background: Estrogens disrupt bile acid (BA) homeostasis and contribute to the development of intrahepatic cholestasis of pregnancy (ICP). ICP is associated with increased serum BA and bilirubin levels, pruritus, and a higher risk of adverse perinatal outcomes. The constitutive androstane receptor (CAR) plays a key role in regulating genes involved in xenobiotic metabolism and BA...

    Go to contribution page
  21. Feng Li (Baylor College of Medicine)
    Cytochrome P450 Enzymes (CYPs)

    See the attachment.

    Go to contribution page
  22. Dr Sylvie Kandel (University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences)
    Drug-Drug and Herb-Drug Interactions

    Abstract:
    Background: Human pregnancy relies on tightly controlled maternal estradiol (E2) levels, which are essential to maintain the pregnancy to full term. However, recent studies have indicated hormonal dysregulation of pregnant people receiving antiretroviral therapy, including the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz. Effectively, efavirenz was...

    Go to contribution page
  23. Mr Shiqing Li ((1)Zunyi Medical University, Key Laboratory of Basic Pharmacology of the Ministry of Education and Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, Zunyi, 563000, China)
    New Tools for Studying Drug Metabolism

    Background: Cytochrome P450 1A2 (CYP1A2) is a critical isozyme involved in drug metabolism and drug-drug interactions. Developing functional probes that combine high selectivity and suitability for both cell imaging and high-throughput screening (HTS) is crucial for accurately assessing CYP1A2 activity and inhibitor discovery.
    Methods: In this study, a series of CYP1A2-specific fluorescent...

    Go to contribution page
  24. Linxiu Tang (中国药科大学)
    Others

    Abstract
    Background: Cardiac biomarkers are widely accepted as diagnostic indicators for myocardial infarction. Their prognostic value has also been approved in the short to medium term outcomes of myocardial infarction. However, their utility in assessing long-term prognosis remains unclear in acute myocardial infarction (AMI).
    Methods: Utilizing the MIMIC-III database, the study included...

    Go to contribution page
  25. Dong-zhu Tu, Guangbo Ge (Shanghai University of Traditional Chinese Medicine)
    Cytochrome P450 Enzymes (CYPs)

    Drug-induced liver injury (DILI) is a leading cause of acute liver failure with limited therapeutic options. Cytochrome P450 2E1 (CYP2E1) plays a critical role in DILI pathogenesis by catalyzing the bioactivation of hepatotoxic drugs into reactive intermediates and generating oxidative stress, creating a self-perpetuating injury cycle. However, clinical translation of CYP2E1 inhibitors has...

    Go to contribution page
  26. Mei Hong (South China Agricultural University)
    Ion Channels and Transporters

    Please see attachment.

    Go to contribution page
  27. Ms Yu Liu ((1)Zunyi Medical University, Key Laboratory of Basic Pharmacology of the Ministry of Education and Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, Zunyi, 563000, China)
    Drug-Drug and Herb-Drug Interactions

    Background: ALDH1A1 is a key enzyme mediating the metabolic activation of Isosorbide 5-Mononitrate (IS?5?MN). IS-5-MN is frequently co-administered with traditional Chinese medicines (TCMs) in clinical practice. This study aimed to establish an ALDH1A1 activity evaluation system and identify relevant TCM inhibitors for rational co-medication.
    Methods: As theophylline acetaldehyde (TA) as a...

    Go to contribution page
  28. Yi Chien Tang
    DMPK (Drug Metabolism and Pharmacokinetics) of New Molecules

    Cytochrome P450 2U1 (CYP2U1) is an extrahepatic, lipid-metabolizing membrane enzyme. Due to its high expression in the thymus, this study investigated CYP2U1-mediated biotransformation of two tumor-targeting tyrosine kinase inhibitors, sorafenib and sunitinib, both commonly prescribed for thymus cancers. For comparison, CYP2U1 and CYP2D6 were incorporated into nanodiscs, and their metabolic...

    Go to contribution page
  29. Ms Anqi Li (School of Pharmaceutical Sciences, Southern Medical University)
    Ion Channels and Transporters

    Background: Hepatocellular carcinoma (HCC) is characterized by hypervascularity and profound resistance to current anti-angiogenic therapies. Endothelial metabolic reprogramming is recognized as a critical driver of tumor angiogenesis, yet the key metabolic regulators within tumor endothelial cells (TECs) in HCC remain largely unknown. This study aims to identify these regulators and...

    Go to contribution page
  30. Minmin Qu
    Cytochrome P450 Enzymes (CYPs)

    Conflict of Interest
    All authors are employees and shareholders of MileCell Biotechnology Inc. Related patents have been filed.

    Background and Purpose
    Primary hepatocytes serve as essential in vitro models for drug metabolism and toxicology studies. However, during culture—particularly in non-human species such as Beagle dogs and rats—the expression of drug-metabolizing enzymes...

    Go to contribution page
  31. Jiahao Li (The Chinese University of Hong Kong)
    DMPK (Drug Metabolism and Pharmacokinetics) of New Molecules

    Purpose
    Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) is a neurodegenerative disease caused by DNA mutation and currently lacking effective treatments to halt its progression [1]. Recent studies had identified piperine as a potential therapeutic agent for FXTAS [2]. However, its low aqueous solubility (0.04 mg/mL) [3] limited its investigations at higher doses. Our previous study...

    Go to contribution page
  32. Yu-Jin Lee (Chonnam National University)
    Drug-Drug and Herb-Drug Interactions

    [Background]
    Xanthoxylin (2′-hydroxy-4′,6′-dimethoxyacetophenone) is a natural compound found in traditional medicinal plants such as Zanthoxylum species, which have been used for pain relief and inflammatory conditions. While several biological activities have been reported in vitro, the metabolic fate of xanthoxylin in humans remains completely unknown. Understanding its metabolism by human...

    Go to contribution page
  33. Xinlin Liang (School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China. Corresponding to J-H F, fangjh6@smu.edu.cn.)
    Drug Metabolism under Different Physiological Conditions

    Background & Question: Metastasis is the primary cause of death in hepatocellular carcinoma (HCC), a highly metabolic malignancy. Although bile acids are recognized as pleiotropic signaling metabolites, most studies have focused on total bile acid pools and their canonical nuclear receptors, leaving the functional contributions of individual bile acid species largely unexplored....

    Go to contribution page
  34. Ms Maolin Chen (Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand;)
    Others

    Abstract
    Background: Venetoclax (VEN) shows marked interindividual pharmacokinetic (PK) variability that may affect therapeutic response. As prolonged antibiotic exposure is common in hematologic malignancies and gut microbiota regulates bile acid–mediated solubilization of poorly water-soluble drugs, we investigated whether microbiota disruption alters VEN PK.
    Methods: A pseudo-germ-free...

    Go to contribution page
  35. Fang Huang (School of Pharmaceutical Sciences, Southern Medical University)
    Metabolism of Natural Products and Endogenous Substances

    Background: The hepatocellular carcinoma (HCC) microenvironment is characterized by aberrant vasculature, which drives therapeutic resistance and poor prognosis. Vascular normalization strategies can restructure tumor vessels and improve immune infiltration. To date, whether and how a high-fat diet (HFD) modulates tumor vascular function in HCC remains unclear.
    Methods: We established...

    Go to contribution page
  36. Ms Yaping Bi (Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou 450001, China)
    Nuclear Receptors & Noncoding RNAs in Drug Metabolism

    Abstract
    Background:
    The induction of cytochrome P450 3A4 (CYP3A4) mediates critical drug-drug interactions and variability in drug response. While ligand-activated PXR drives CYP3A4 transcription, the mechanism enabling efficient transcriptional complex assembly remains unclear. This study investigates whether the long non-coding RNA HNF1A-AS1 regulates this process by promoting...

    Go to contribution page
  37. Sasa Zhang (State Key Laboratory of Natural Medicines,China Pharmaceutical University)
    Others

    Background: Epimedii Folium (EF) is a flavonoid-rich botanical resource with broad bioactivity and potential application as a plant-derived functional ingredient. However, its hepatic effects may depend on host physiological state and co-administered botanical components.

    Methods: The present study investigated the hepatic responses to EF under normal and immune-stressed conditions and...

    Go to contribution page
  38. 秀丽 高 (贵州医科大学)
    Others

    Polyethylene glycol 400 (PEG 400), a pharmaceutical excipient approved by both the U.S. Food and Drug Administration and the Chinese Pharmacopoeia, is widely employed in clinical formulations due to its favorable biocompatibility and hydrophilicity. Therefore, whether PEG induces excipient-drug interactions and alters the in vivo disposition of active pharmaceutical ingredients has become a...

    Go to contribution page
  39. 一 赵 (中国医学科学院药物研究所)
    Drug Metabolism under Different Physiological Conditions

    Background: Increasing research suggests that the gut microbiota serves as a critical metabolic barrier for oral drug absorption. This study aims to investigate whether the commonly used clinical drugs proton pump inhibitors (PPIs) undergo metabolism within the gut microbiota.
    Methods: Two representative PPIs, omeprazole (OME) and pantoprazole (PAN), was investigated using an in vitro...

    Go to contribution page
  40. Ms Xiaoyi Zhong (Southern Medical University), Dr Yanying Zhou (Southern Medical University), Prof. Huichang Bi (Southern Medical University)
    Metabolism of Natural Products and Endogenous Substances

    Inhibition of CPT1C ameliorates osteoporosis by regulating αKG levels through interaction with OGDH
    Zhong Xiaoyi1, #, Zhu Linlin1, #, Li Julin1, Fang Jian-Hong1, Zhou Yanying1, , Bi Huichang1, *
    1 School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
    Correspondence to: Huichang Bi, bihchang@smu.edu.cn
    Background: Osteoporosis is characterized by suppressed...

    Go to contribution page
  41. Yufeng Zhang (CUHK)

    Background: The analgesic effects of opioids are mediated through four known receptors: mu (MOR), kappa (KOR), delta (DOR), and opioid receptor-like 1 (ORL-1). Of opioid analgesics, mu-opioid agonists (MOAs) are the most commonly used. 2-hydroxytriazolo[4,5-b]pyridine was synthesized as a potential MOA. Pyridines inhibit P-glycoprotein and can reverse multidrug resistance in cancer cells. They...

    Go to contribution page
  42. Songrong Ren (University of Pittsburgh)
    Cytochrome P450 Enzymes (CYPs)

    Activation of extracellular matrix (ECM)-producing hepatic stellate cells (HSCs) is a key event in liver fibrogenesis. We showed that the expression of heme-thiolate monooxygenase CYP1B1 was elevated in human and mouse fibrotic livers and activated HSCs. Systemic or HSC-specific ablation as well as pharmacological inhibition of CYP1B1 attenuated HSC activation and protected mice from...

    Go to contribution page
  43. Mengxin Huang ((1) School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China (2)Drug Clinical Trial Institution, The First Affiliated Hospital of Xiamen University, Xiamen, China)
    Cytochrome P450 Enzymes (CYPs)

    Background:
    C019199 is a novel oral CSF-1R inhibitor for tenosynovial giant cell tumor and other solid tumors. However, the inhibitory and inducible effects of C019199 on the activity of cytochrome P450 (CYP450) is unclear.
    Method:
    Human liver microsomes and primary hepatocytes were used as in vitro models.
    Results:
    C019199 was rapidly metabolized with poor stability across species...

    Go to contribution page
  44. Dr Yingtong Xu (University of Bern)
    Cytochrome P450 Enzymes (CYPs)

    Context: Genotype-phenotype correlations in congenital adrenal hyperplasia (CAH) are often complicated by rare CYP21A2 missense variants classified as Variants of Uncertain Significance (VUS).

    Objective: To resolve the pathogenicity and structural mechanisms of eleven CYP21A2 variants (p.L10del, p.R76K, p.E162G, p.S274Y, p.L308V, p.S373N, p.P387L, p.H393Q, p.R401G, p.R436C, and...

    Go to contribution page
  45. F. Peter Guengerich (Vanderbilt University)
    Cytochrome P450 Enzymes (CYPs)

    Abstract:
    Background: Cytochrome P450 (P450) enzymes are major catalysts involved in the metabolism of drugs, steroids, and fatty acids–hydrophobic molecules that interact with intracellular binding proteins in vivo. A focus is fatty acid binding protein 1 (FABP1), present in liver cytosol at ≥400 µM and reported to bind drugs tightly.
    Methods: Purified recombinant human P450s and FABP1 were...

    Go to contribution page
  46. Ziyi Zhou ((1) School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China (2)Drug Clinical Trial Institution, The First Affiliated Hospital of Xiamen University, Xiamen, China)
    DMPK (Drug Metabolism and Pharmacokinetics) of New Molecules

    Abstract:

    Background: C019199 is a novel oral inhibitor of CSF1R currently in clinical trials. This study aimed to characterize its interspecies metabolic profiles and to evaluate the kinase inhibitory activity of its major circulating metabolite, M7 (also known as Y019009-L).

    Methods: C019199 was incubated with human, monkey, dog, rat and mouse liver microsomes. Metabolites...

    Go to contribution page
  47. Paul Chukwudi Ikwegbue
    Cytochrome P450 Enzymes (CYPs)

    Prostate cancer remains one of the most diagnosed cancers in men. Surgical interventions and radiation therapy are typically employed for early-stage disease, while androgen deprivation therapy (ADT) is used for metastatic cases. However, relapses and treatment resistance often occur over time. A key factor in this resistance is the overproduction of androgens, driven by activation of...

    Go to contribution page
  48. Dr Chen Cheng (Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
    Others

    Background: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder in which impaired intestinal barrier integrity contributes to immune activation, visceral hypersensitivity, and disrupted gut–brain communication. Peppermint oil, rich in l-menthol, is clinically effective for IBS symptom relief; however, its role in improving intestinal barrier function remains...

    Go to contribution page
  49. Dr Yingtong Xu (University of Bern)
    Metabolism of Natural Products and Endogenous Substances

    Human cytochrome P450 17A1 (CYP17A1) serves as the gatekeeper of steroidogenesis, partitioning precursors into glucocorticoid or androgen biosynthetic pathways and serving as a critical target for prostate cancer therapy. Despite the availability of static crystal structures, the dynamic pathways by which lipophilic substrates access the buried heme active site from the endoplasmic reticulum...

    Go to contribution page
  50. Ms Xinyan Zhu (Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmaceutical Sciences, Fudan University, Shanghai, China)
    Drug-Drug and Herb-Drug Interactions

    Abstract

    Background: Physiologically based pharmacokinetic (PBPK) models are increasingly used as surrogates for clinical trials in regulatory submissions, yet features distinguishing regulatory-adopted models from academic research remain poorly characterized. This study aimed to identify factors associated with regulatory adoption of PBPK drug-drug interaction (DDI) models through...

    Go to contribution page
  51. Ms Jiyeon Hong (Konkuk university)
    Cytochrome P450 Enzymes (CYPs)

    Background: Cytochrome P450 17A1 (CYP17A1) is a key steroidogenic enzyme that catalyzes both 17α-hydroxylase and 17,20-lyase reactions, thereby regulating glucocorticoid and sex steroid biosynthesis. Cytochrome b5 (b5) is known to selectively enhance the 17,20-lyase activity of CYP17A1; however, the molecular mechanism underlying this modulation remains incompletely...

    Go to contribution page
  52. Prof. Pan Deng (Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China)
    DMPK (Drug Metabolism and Pharmacokinetics) of New Molecules

    Background: Recent advances in lipid nanoparticle delivery (LNP) systems have enabled the development of mRNA vaccines and oligonucleotide therapeutics. Reliable hepatic in vitro systems are essential for the evaluation of metabolism of LNP components and RNA therapeutics.

    Methods: The 3D liver spheroid models were constructed using mouse and rat primary hepatocytes as well as HepG2 cell...

    Go to contribution page
  53. 洁 王 (上海药明康德新药开发有限公司)
    Others

    Background: Determining nonspecific binding in liver microsomes is critical for kinetic estimation but difficult for highly bound compounds due to methodological biases. This study compares three common dialysis techniques (equilibrium, pre-saturation, and flux) to assess how equilibration time and protein stability affect fraction unbound (fu) results, ultimately providing recommendations for...

    Go to contribution page
  54. Mr Štefan Šatka (Palacký University Olomouc)
    Cytochrome P450 Enzymes (CYPs)

    The gut microbiota plays a vital role in maintaining human health by contributing to nutrient metabolism, immune function, and the production of bioactive metabolites, and is implicated in inflammatory, metabolic, and neurological disorders, underscoring its important influence on human physiology. Beyond these roles, the gut microbiota is increasingly recognized as an important factor...

    Go to contribution page
  55. YUJI ISHII (Graduate School of Pharmaceutical Sciences, Kyushu University)
    Cytochrome P450 Enzymes (CYPs)

    UDP-glucuronosyltransferases (UGTs) and cytochromes P450 (P450s, CYPs) are a family of enzymes that catalyze glucuronidation and oxidation. Although these are membrane proteins bound to the endoplasmic reticulum, their topologies are distinct. Therefore, these proteins are considered to function independently. Cumulative evidence suggests that protein¬¬–protein interactions exist between P450...

    Go to contribution page
  56. Prof. Edward Kelly (University of Washington)
    New Tools for Studying Drug Metabolism

    Our group at the University of Washington focuses on the development of microphysiological models as an alternative to animal testing. I will present case studies on the application of these new approach methodologies (NAMs) in modeling ADME disposition and toxicity of drugs, endobiotics and xenobiotics. These studies are based on the “holy trinity” of ADME NAMs-the intestine, liver and...

    Go to contribution page
  57. Prof. B Moorthy (Baylor College of Med)
    Drug Metabolism under Different Physiological Conditions

    Supplemental oxygen administration is frequently encountered in infants and adults with pulmonary insufficiency. Hyperoxia contributes to acute respiratory distress syndrome (ARDS) in humans. In this investigation, we tested the hypotheses that (i) hyperoxia induces CYP1A1 via the formation of 6-Formylindolo[3,2-b]carbazole (FICZ), an endogenous ligand for the Ah receptor (AHR; and (ii) FICZ...

    Go to contribution page
  58. Bin Guo (Hunan Normal University)
    Metabolism of Natural Products and Endogenous Substances

    Background: Pirin, a non-heme metalloprotein that occurs widely in human tissues, typically functions as nuclear transcription regulators involved in cancer metastasis. We first revealed that Pirin homologs have the activity of "flavonolase" (quercetinase-like), i.e. catalyzing the oxidative decomposition of plant flavonols with the release of carbon monoxide (CO). (Guo et al.: *ACS...

    Go to contribution page
  59. Prof. Ling Yang (Key Laboratory of Basic Pharmacology of Ministry of Education & Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, China)
    Drug-Drug and Herb-Drug Interactions

    Abstract:
    Background: This study used capecitabine (CAP) as a model prodrug to investigate localized accumulation of active metabolite 5-fluorouracil (5-FU) caused by premature gastrointestinal activation mediated by carboxylesterase (CES). It explored oleanolic acid (OA), a natural CES inhibitor, to delay metabolic activation of CAP in non-target organs, aiming to improve heterogeneous...

    Go to contribution page
  60. Dr Huanguo Jiang (Southern Medical University)
    Metabolism of Natural Products and Endogenous Substances

    Background: Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive triglyceride (TG) accumulation in hepatocytes, leading to progressive liver injury. Carboxylesterases CES1 and CES2 are critical hepatic lipolytic enzymes, yet their expression and activity are suppressed in obesity. Therapeutic strategies to restore CES1/2 function remain limited.
    Methods: High-fat diet...

    Go to contribution page
  61. Isabel S. Barata (University of Bern, Switzerland)
    Others

    Background: Cytochrome P450 oxidoreductase (POR) is the master regulator for activities of microsomal P450 enzymes, governing critical pathways in steroidogenesis and drug metabolism. However, the specific role of POR dysregulation and somatic variation in cancer progression and patient outcome remains poorly defined. This study aimed to identify which cancers are vulnerable to POR...

    Go to contribution page
  62. Mr Si-Tao Xu (Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China)
    Metabolism of Natural Products and Endogenous Substances

    Abstract
    Background and Aims:
    Metabolic dysfunction-associated steatotic liver disease (MASLD) has progressed as the most prevalent chronic liver disease globally, affecting over one-third of the world’s population. The perilipin (Plin) family proteins play a crucial role of hepatic lipid droplets (LDs) accumulation in MASLD. This study demonstrates that Paeonol serves as a potential...

    Go to contribution page
  63. Mr Longjie Li (Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmaceutical Sciences, Fudan University, Shanghai, China)
    Metabolism of Natural Products and Endogenous Substances

    Authors:
    Longjie Li (1)†, Mengfan Ye (2) (3)†, Wenhang Xu (1), Xinyan Zhu (1), Haiping Xu (1), Qingfeng He (1), Xiao Zhu (1), Juan Xie (2) (3), Xiaoqiang Xiang (1)

    Affiliations:
    (1) Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmaceutical Sciences, Fudan University, Shanghai, China
    (2) Department of General Medicine at Shanghai Fifth People's Hospital,...

    Go to contribution page
  64. Yu Lu (Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan)
    Others

    Background: 5F-CUMYL-PeGACLONE (5F-CP) is a novel synthetic cannabinoid containing a 5-fluoropentyl side chain and previous studies have suggested that its toxic effects are not restricted to the nervous system. Synthetic cannabinoids primarily act via the cannabinoid receptor type 1 (CB1) pathway; CB1 activation is generally associated with increased hepatic lipid production. However,...

    Go to contribution page
  65. Xin-Yi Tang (Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmaceutical Sciences, Fudan University)
    Drug Metabolism under Different Physiological Conditions

    Background: Patients with obstructive sleep apnea (OSA) are highly vulnerable to airway obstruction and respiratory depression under anesthesia. Understanding the pharmacodynamic behavior of remimazolam, a short-acting benzodiazepine, in this specific population is essential for optimizing dosing and minimizing anesthetic risk.
    Methods: Forty-four participants received stepwise escalating...

    Go to contribution page
  66. Ms Aran Seo (Seoul National University)
    DMPK (Drug Metabolism and Pharmacokinetics) of New Molecules

    Background: MG1113 is a humanized immunoglobulin G4 antibody targeting tissue factor pathway inhibitor (TFPI), currently under clinical development for hemophilia. This study aimed to refine a previously developed TMDD model for MG1113 by incorporating both soluble and membrane-bound TFPI (sTFPI-α and mTFPI) along with a transit compartment. Furthermore, we investigated the impact of...

    Go to contribution page
  67. Jiaqi Wang (Chinese Academy of Sciences Shanghai Institute of Materia Medica)
    Others

    Background: Sepsis remains a major global health challenge, with limited effective therapies targeting dysregulated host responses. Patient heterogeneity represents a critical barrier to treatment optimization. Currently, XueBiJing injection is the only effective agent shown to modulate dysregulated host responses. This study aimed to characterize the pharmacokinetics of XueBiJing in...

    Go to contribution page
  68. Dr Zixia Hu (Shenyang Pharmaceutical University)
    Metabolism of Natural Products and Endogenous Substances

    Furanoterpenoid diosbulbin B (DSB) is a major component responsible for the hepatotoxicity of herbal medicine Dioscorea bulbifera L. (DBL). The metabolic oxidation of the furan moiety of DSB is considered to initiate its liver toxicity. The resulting reactive intermediate reacts with hepatic protein to form protein covalent binding. DSB-derived protein adduction-based biomarker was...

    Go to contribution page
  69. Qingqing Yu (Southern Medical University)
    Others

    Background: Rituximab (RTX) is widely used off-label for pediatric patients with frequently relapsing or steroid-dependent nephrotic syndrome (FRNS/SDNS), yet dosing remains extrapolated from B-cell lymphoma regimens. This study characterizes population pharmacokinetics and exposure-response to inform optimal pediatric dosing.
    Methods: Thirty-one pediatric patients with FRNS/SDNS were...

    Go to contribution page
  70. Seongsoo Lee (Seoul National University)
    DMPK (Drug Metabolism and Pharmacokinetics) of New Molecules

    Background: The hexapeptide WKYMVm (Wm), a potent agonist of the formyl peptide receptor 2, has shown therapeutic potential in various disease models (e.g., sepsis, lung injury, and cancer). Given that peptide-based drug candidates are often limited by rapid enzymatic degradation and poor membrane permeability, this study investigated the metabolic pathways and oral dosing feasibility of...

    Go to contribution page
  71. 俊晓 陈 (南方医科大学)
    Nuclear Receptors & Noncoding RNAs in Drug Metabolism

    Background: Hepatic ischemia‑reperfusion injury (HIRI) remains a major challenge in liver surgery. The pregnane X receptor (PXR) is a key regulator of xenobiotic metabolism and cellular stress responses, yet its role in HIRI is poorly defined. Here, we investigated the function of PXR in both vivo and in vitro models of liver IRI.
    Methods: To investigate the role of PXR in hepatic I/R injury,...

    Go to contribution page
  72. Yisheng He (Chinese University of Hong Kong-Shenzhen)
    Metabolism of Natural Products and Endogenous Substances

    Background: Hepatic sinusoidal obstruction syndrome (HSOS) is a fatal vascular liver disease characterized by liver sinusoidal endothelial cell (LSEC) injury. Exposure to pyrrolizidine alkaloids (PAs), the most common plant toxins found in herbal medicines and contaminated food products, is a leading cause of HSOS. However, why PAs specifically damage LSEC rather than initially targeting...

    Go to contribution page
  73. Ms Juhyoung Kang (Seoul national university)
    Drug Metabolism under Different Physiological Conditions

    Background: Escitalopram (S-CIT) is widely prescribed for depression and anxiety in older adults. A previous study indicated that the impact of CYP2C19 phenotypes on S-CIT pharmacokinetics is more pronounced in older adults than in younger individuals (Jang et al., Clin Pharmacol Ther 2025). This study quantified the risk of drug-drug interactions (DDIs) involving S-CIT in older and...

    Go to contribution page
  74. Mr Ruixing Li (DMPK Department, WuXi AppTec)
    DMPK (Drug Metabolism and Pharmacokinetics) of New Molecules

    Abstract:
    Background: The formation and accumulation of payload-related catabolites from antibody–drug conjugates (ADCs) in targeted and normal tissues are directly associated with ADC's efficacy and systemic toxicity. Rapid and comprehensive identification of these catabolites in vitro is important for supporting the payload/linker design and facilitating preclinical evaluation of ADCs....

    Go to contribution page
  75. Dr Katyayani Sharma (University of Bern, Switzerland)
    Cytochrome P450 Enzymes (CYPs)

    NADPH cytochrome P450 oxidoreductase (POR) is an essential redox protein that functions as an electron donor and central regulator of over 50 partner proteins, including the cytochrome P450 enzyme network (1). While naturally occurring mutations in POR are known to disrupt steroidogenesis and drug metabolism, the molecular mechanisms by which POR sequence variations influence structural...

    Go to contribution page
  76. Jibira Yakubu (University of Bern)
    Cytochrome P450 Enzymes (CYPs)

    Castration-resistant prostate cancer (CRPC) remains largely driven by persistent androgen receptor (AR) signalling, making CYP17A1 inhibition a validated therapeutic strategy. However, first-generation inhibitors such as abiraterone lack enzymatic selectivity, suppressing both 17α-hydroxylase and 17,20-lyase activities and leading to off-target endocrine disturbances. Seviterenol (VT-464) is a...

    Go to contribution page
  77. Zijian He (Southern Medical University)
    Drug Metabolism under Different Physiological Conditions

    Background: Sleep deprivation (SD) impairs diverse physiological functions and contributes to multi-system disorders, emerging as a prevalent public health concern. It has been demonstrated that SD disrupts metabolic homeostasis and drives liver disease progression, from non-alcoholic fatty liver disease to hepatocellular carcinoma. However, the consequences of SD on hepatic cytochrome P450...

    Go to contribution page
  78. kaige li (bern)
    Cytochrome P450 Enzymes (CYPs)

    Kaige Li1,2,3, Jibira Yakubu1,2,3, Flemming Steen Jørgensen4 , Amit V. Pandey1,2,*

    1Pediatric Endocrinology, Diabetology and Metabolism, University Children’s Hospital, Inselspital, Bern, Switzerland.
    2Translational Hormone Research Program, Department of Biomedical Research, Faculty of Medicine, University of Bern, Bern, Switzerland.
    3Graduate School for Cellular and Biomedical...

    Go to contribution page
  79. Jiaxin Zhang (HongKong Baptist University)
    Metabolism of Natural Products and Endogenous Substances

    Ulcerative colitis (UC) is a chronic inflammatory bowel disease with complex pathogenesis. Globally, the number of UC cases has reached 5 million, posing a significant threat to public health and imposing a substantial economic burden worldwide. There is currently a lack of highly effective and accessible clinical medications. Our previous studies have demonstrated that oxidized berberine...

    Go to contribution page
  80. Qi Chen (Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.)
    Cytochrome P450 Enzymes (CYPs)

    Background: CYP3A4 and 3A7 specifically catalyze the tertiary oxidation of deoxychoate (DCA) and glycodeoxycholate (GDCA). The oxidation rates fit well with Hill kinetic model at low substrate concentrations (DCA 1-400 μM, GDCA 30-250 μM), but gradually decrease as substrate levels increase, eventually leading to complete enzyme deactivation above the critical micelle concentration (CMC)....

    Go to contribution page
  81. Jianglian She
    Metabolism of Natural Products and Endogenous Substances

    Title:
    Targeting LXRα-R305 Covalent Activation for Renal Copper Homeostasis Restoration by Marine Pestaphilone A as an Anti-AKI candidate
    Authors:
    Jianglian She (1, 2, 3, 4), Yi Chen (1, 2, 3, 4), Tanwei Gu (2), Xi Zhang (2), Huanguo Jiang (2), Wenxun Lan (2), Lan Tang (2, 3), Xuefeng Zhou (1, 3)
    Affiliations:
    (1) State Key Laboratory of Tropical Oceanography, Guangdong Key Laboratory...

    Go to contribution page
  82. Jia Xue (Huaxi University)
    Others

    The UGT2B7 glucuronidation activity affected by its homo- or dimerization
    Authors:
    J. Xue (1), H.T. Zhang (2), S. Zeng (2)
    Affiliations:
    (1)West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
    (2) College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China
    Abstract:
    Background: UGT2B7 is one of the most important UGTs that glucuronidates...

    Go to contribution page
  83. Dr Oliver Burk (RBMF / Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology)
    Nuclear Receptors & Noncoding RNAs in Drug Metabolism

    Double limitation characterizes the use of nuclear receptor (NR) modulation in cancer pharmacotherapy. First, it is approved in only few cancer entities. Second, it is restricted to a small number of NRs. In this study, we aimed to reveal the full potential of NRs as drug targets in anti-cancer therapy by combining bioinformatics, molecular biology and biochemical approaches.
    Genome-wide gene...

    Go to contribution page
  84. Cheng Qian (School of Pharmaceutical Sciences, Fudan University, Shanghai, China)
    Others

    Background
    Daptomycin exhibits large inter-individual pharmacokinetic variability, with efficacy and safety linked to exposure metrics. Population pharmacokinetic (PopPK) models enable model-informed precision dosing (MIPD), but their external predictive performance and clinical transferability in elderly patients remain unevaluated.
    Methods
    Published daptomycin PopPK models were identified...

    Go to contribution page
  85. Ping Xiao (Bern university)
    New Tools for Studying Drug Metabolism

    Title:
    Traceless cofactor regeneration from formate for CYP450 enzyme cascades

    Authors:

    Ping Xiao (1), Jibira Yakubu (2), Amit V Pandey (2), Christoph von Ballmoos (1)

    Affiliations

    (1) University of Bern, Department of Chemistry, Biochemistry and Pharmacy, Freiestrasse 3, 3012 Bern, Switzerland

    (2) University of Bern, Department for BioMedical Research,...

    Go to contribution page
  86. Fikri Ainur Risma Hardiyanti (Chonnam National University)
    Others

    Background: The synthesis of human drug metabolites (HDMs) is one of the fundamental aspects in pharmacokinetic and pharmacodynamic safety studies, as the U.S. Food and Drug Administration (FDA) requires evaluation of metabolites formed exceeding 10% systemic exposure of the parent drug. Conventional chemical synthesis of HDMs is often limited by low yields and complex procedures, highlighting...

    Go to contribution page
  87. Yusun Seo (Chonnam National University)
    New Tools for Studying Drug Metabolism

    Background: Drug metabolism studies play a critical role in drug development by enabling the prediction of pharmacokinetics and potential drug–drug interactions. Conventional cytochrome P450 enzymes are commonly used for these studies. Unspecific peroxygenases (UPOs), heme-thiolate enzymes structurally related to P450s, have recently emerged as promising alternatives. Unlike P450s, UPOs...

    Go to contribution page
  88. Sulaiya Talaiti (School of Pharmaceutical Sciences, Southern Medical University)
    Others

    Background: Valine‑tRNA synthetase (VARS), a key member of aminoacyl‑tRNA synthetases, catalyzes valine‑tRNA formation and maintains translational fidelity. Our preliminary TCGA analysis demonstrated that VARS is significantly upregulated in hepatocellular carcinoma (HCC) tissues, and high VARS expression correlates with poorer overall and disease‑free survival, suggesting VARS functions...

    Go to contribution page